Professor Blasczyk has a long term research interest in solid organ transplantation and transplantation immunology with a main focus on transplant tolerance and transplant engineering. His work centers around the alloimmune response in organ transplantation and therapeutic interventions to combat rejection and infection. This includes cellular and humoral immunotherapy as well as genetic and transplant engineering approaches to achieve transplantation tolerance.
Professor Blasczyk is founder and chairman of the Immunotherapy Foundation. He has been a member of the Advisory Board on Blood Products of the German Ministry of Health, President of the German Society of Immunogenetics (DGI) and the German Society of Transfusion Medicine and Immunohematology (DGTI) as well as a Board Member of the European Society of Immunogenetics (EFI).